Ankur Butala is a Neurology physician affiliated with Johns Hopkins University. OpenAlex indexes 71 publications with 663 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Meyer 6-181
Baltimore, MD 212870005
Telephone
410-502-0133Provider last certified this registry record 12 Feb 2024.
Clinical trials
- Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome
Sponsor: Johns Hopkins University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- REVANCE THERAPEUTICS, INC.Program year20241 payment
- ACADIA Pharmaceuticals IncProgram year20221 payment
- ACADIA Pharmaceuticals IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.3%Aromatic Amino Acid Decarboxylation Inhibitor31.4%Carbidopa-Levodopa42%Rytary36%Carbidopa-Levodopa Er20%Carbidopa2%Part D<11 patientsCholinesterase Inhibitor12%Rivastigmine67%Pyridostigmine Bromide20%Donepezil Hcl7%Galantamine Er6%Part D<11 patients+ 18 more classes in this area
Cardiovascular
4.2%Beta blocker1.9%Propranolol Hcl50%Propranolol Hcl Er50%Part D<11 patientsAdrenergic and dopaminergic agents1.3%Droxidopa100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
1.8%gamma-Aminobutyric Acid-ergic Agonist1.8%Baclofen100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Integrating tele-palliative care for atypical Parkinsonian disorders: Lessons learned from a pilot program
Clinical Parkinsonism & Related Disorders
2025 - Interpretable Features for the Assessment of Neurodegenerative Diseases Through Handwriting Analysis
IEEE Journal of Biomedical and Health Informatics
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Laheru, MD
Johns Hopkins University
Demosthenes G. Katritsis
Johns Hopkins University
Tanguy Seiwert, MD
Johns Hopkins University
Evan Lipson, MD
Johns Hopkins University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”